Arctic Bioscience AS 

€0.24
0
+€0+0% Friday 14:31

Statistics

Day High
-
Day Low
-
52W High
0.39
52W Low
0.14
Volume
-
Avg. Volume
17
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 9TD.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CD Projekt.
CDR.WA
Mkt Cap12.87B
Comarch SA offers similar enterprise resource planning (ERP) software and services, directly competing in the same market segments as Asseco Business Solutions.
Sap
SAP
Mkt Cap191.79B
SAP SE is a global leader in ERP and business solutions, competing on a larger scale but directly with Asseco Business Solutions in various markets.
Microsoft
MSFT
Mkt Cap2.76T
Microsoft Corporation, through its Dynamics 365 suite, offers ERP and CRM solutions that compete with Asseco Business Solutions' offerings.
Oracle
ORCL
Mkt Cap397.15B
Oracle Corporation provides ERP solutions and cloud services that compete with Asseco Business Solutions in the enterprise and mid-market segments.
Intuit
INTU
Mkt Cap97.66B
Intuit Inc., with its financial and business management solutions for small businesses, competes with Asseco Business Solutions' offerings aimed at similar market segments.
Adobe
ADBE
Mkt Cap91.86B
Adobe Inc. competes in the digital experience and marketing solutions space, overlapping with some of Asseco Business Solutions' software offerings.
International Business Machines
IBM
Mkt Cap216.55B
International Business Machines Corporation offers a wide range of enterprise software and cloud solutions that compete with Asseco Business Solutions in various sectors.
Salesforce
CRM
Mkt Cap154.57B
Salesforce.com, Inc. is a leading provider of CRM software and cloud-based solutions, competing with Asseco Business Solutions in the CRM and business solutions market.
Schroder Global Equity Active UCITS USD ACC
SAGE.LSE
Mkt Cap0

About

Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Show more...
CEO
Mr. Christer L. Valderhaug
Employees
22
Country
Other
ISIN
NO0010859580

Listings

0 Comments

Share your thoughts

FAQ

What is Arctic Bioscience AS stock price today?
The current price of 9TD.STU is €0.24 EUR — it has increased by +0% in the past 24 hours. Watch Arctic Bioscience AS stock price performance more closely on the chart.
What is Arctic Bioscience AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Arctic Bioscience AS stocks are traded under the ticker 9TD.STU.
Is Arctic Bioscience AS stock price growing?
9TD.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Arctic Bioscience AS has showed a -32.39% decrease.
When is the next Arctic Bioscience AS earnings date?
Arctic Bioscience AS is going to release the next earnings report on April 30, 2026.
How many employees does Arctic Bioscience AS have?
As of April 15, 2026, the company has 22 employees.
In which sector is Arctic Bioscience AS located?
Arctic Bioscience AS operates in the Health & Wellness sector.
When did Arctic Bioscience AS complete a stock split?
Arctic Bioscience AS has not had any recent stock splits.
Where is Arctic Bioscience AS headquartered?
Arctic Bioscience AS is headquartered in Ørsta, Other.